Ameriprise’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$78.2M Sell
605,728
-55,661
-8% -$8M 0.02% 653
2025
Q4
$94.4M Sell
661,389
-142,153
-18% -$19M 0.02% 575
2025
Q3
$96.4M Buy
803,542
+203,746
+34% +$25.8M 0.02% 579
2025
Q2
$79.3M Sell
599,796
-93,915
-14% -$12.7M 0.02% 642
2025
Q1
$96.3M Buy
693,711
+108,493
+19% +$16.8M 0.03% 558
2024
Q4
$90.8M Sell
585,218
-41,911
-7% -$7.09M 0.02% 583
2024
Q3
$114M Buy
627,129
+99,809
+19% +$14.8M 0.03% 496
2024
Q2
$62.6M Buy
527,320
+84,827
+19% +$8.92M 0.02% 700
2024
Q1
$47.5M Buy
442,493
+74,488
+20% +$7.41M 0.01% 830
2023
Q4
$36.7M Buy
368,005
+43,138
+13% +$4.22M 0.01% 922
2023
Q3
$38.7M Buy
324,867
+71,258
+28% +$10.6M 0.01% 866
2023
Q2
$45.2M Sell
253,609
-43,435
-15% -$7.97M 0.01% 806
2023
Q1
$49M Buy
297,044
+26,109
+10% +$4.49M 0.02% 764
2022
Q4
$42.7M Buy
270,935
+23,144
+9% +$3.52M 0.01% 794
2022
Q3
$37.3M Buy
247,791
+150,449
+155% +$25M 0.01% 822
2022
Q2
$16M Buy
97,342
+11,939
+14% +$2.3M 0.01% 1378
2022
Q1
$19M Buy
85,403
+9,337
+12% +$2.09M 0.01% 1394
2021
Q4
$18.1M Sell
76,066
-914
-1% -$213K 0.01% 1503
2021
Q3
$18M Sell
76,980
-21,138
-22% -$4.43M 0.01% 1343
2021
Q2
$20.2M Buy
98,118
+2,542
+3% +$523K 0.01% 1351
2021
Q1
$19.6M Buy
95,576
+10,902
+13% +$2.3M 0.01% 1340
2020
Q4
$18.1M Sell
84,674
-15,706
-16% -$3.05M 0.01% 1297
2020
Q3
$18.3M Sell
100,380
-5,376
-5% -$1.01M 0.01% 1125
2020
Q2
$19.5M Buy
105,756
+21,580
+26% +$4.29M 0.01% 1070
2020
Q1
$17M Sell
84,176
-3,068
-4% -$591K 0.01% 1042
2019
Q4
$16.3M Buy
87,244
+8,545
+11% +$1.47M 0.01% 1336
2019
Q3
$12.6M Buy
78,699
+12,031
+18% +$2.4M 0.01% 1518
2019
Q2
$16.8M Buy
66,668
+15,576
+30% +$3.61M 0.01% 1294
2019
Q1
$12.2M Sell
51,092
-2,657
-5% -$637K 0.01% 1531
2018
Q4
$12.3M Sell
53,749
-15,958
-23% -$3.93M 0.01% 1420
2018
Q3
$19.7M Buy
69,707
+4,966
+8% +$1.45M 0.01% 1304
2018
Q2
$19M Buy
64,741
+5,352
+9% +$1.46M 0.01% 1215
2018
Q1
$15M Sell
59,389
-36,225
-38% -$8.51M 0.01% 1336
2017
Q4
$20.7M Sell
95,614
-1,139
-1% -$231K 0.01% 1043
2017
Q3
$18M Sell
96,753
-12,882
-12% -$2.25M 0.01% 1126
2017
Q2
$18.9M Sell
109,635
-17,896
-14% -$2.87M 0.01% 1058
2017
Q1
$19.5M Sell
127,531
-24,122
-16% -$3.53M 0.01% 1036
2016
Q4
$22.3M Buy
151,653
+43,469
+40% +$6.29M 0.01% 928
2016
Q3
$13.7M Sell
108,184
-10,850
-9% -$1.31M 0.01% 1204
2016
Q2
$13.4M Sell
119,034
-13,474
-10% -$1.4M 0.01% 1175
2016
Q1
$13.8M Buy
132,508
+5,892
+5% +$563K 0.01% 1175
2015
Q4
$14.3M Buy
126,616
+14,999
+13% +$1.66M 0.01% 1170
2015
Q3
$12.2M Sell
111,617
-3,030
-3% -$324K 0.01% 1293
2015
Q2
$11M Buy
114,647
+49,964
+77% +$4.67M 0.01% 1517
2015
Q1
$6.02M Buy
64,683
+4,055
+7% +$355K ﹤0.01% 1984
2014
Q4
$4.96M Sell
60,628
-29,656
-33% -$2.27M ﹤0.01% 2063
2014
Q3
$5.79M Sell
90,284
-1,132
-1% -$69.3K ﹤0.01% 1932
2014
Q2
$5.56M Buy
91,416
+9,560
+12% +$564K ﹤0.01% 2014
2014
Q1
$4.9M Sell
81,856
-93,171
-53% -$5.74M ﹤0.01% 2031
2013
Q4
$11.2M Sell
175,027
-140,803
-45% -$9.06M 0.01% 1409
2013
Q3
$21.5M Sell
315,830
-164,265
-34% -$11.7M 0.01% 950
2013
Q2
$34.6M Buy
+480,095
New +$31.7M 0.02% 684

Other funds holding ICUI

Ameriprise's ICUI Position: Q1 2026 in Review

Ameriprise reduced its ICU Medical (ICUI) stake by 8.4% in Q1 2026, selling an estimated $8M and leaving 605,728 shares worth $78.2M. The position accounts for 0.02% of the portfolio, ranked #653.

Ameriprise first reported a position in ICUI in Q2 2013 and has held it in 52 quarters since. The position peaked at $114M in Q3 2024. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Ameriprise held 605,728 shares of ICU Medical worth $78.2M as of Q1 2026.
  • Ameriprise sold 55,661 ICU Medical shares in Q1 2026, an estimated $8M.
  • ICU Medical made up 0.02% of Ameriprise's portfolio in Q1 2026, its #653 holding.
  • Ameriprise first reported a position in ICU Medical in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's ICU Medical position peaked at $114M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.